|
FUTURE OF SURGERY AND CLASSIFICATION
Chair: Stefano Zurrida
Rapporteur: Oreste Gentilini |
| 8.15 |
Extended indications for sentinel
node biopsy procedures and internal
mammary node assessment
Paolo Veronesi |
| 8.35 |
What is the best treatment for lobular invasive
carcinoma?
Viviana Galimberti |
| 8.50 |
Preservation of breast image:
a new avenue in breast surgery
Jean Yves Petit |
| 9.05 |
Future evolution of the TNM: concrete approaches
Umberto Veronesi |
| 9.20 |
Discussion |
|
RADIATION THERAPY:
WHEN, HOW, FOR WHOM
Chair: Patrizia Olmi
Rapporteur: Maria Cristina Leonardi |
| 9.35 |
The rationale for Partial Breast Irradiation:
the Intraoperative Electron beams
radiotherapy (ELIOT)
Roberto Orecchia |
| 9.50 |
ELIOT plus accelerated external radiotherapy
Giovanni Ivaldi |
| 10.05 |
The use of proton beams in the treatment
of breast cancer
Alphonse Taghian |
| 10.20 |
Discussion |
| 10.30 |
Coffee Break |
| 11.00 |
SPOTLIGHT
Assessing margins of excision:
what is it all about?
Umberto Veronesi |
| 11.20 |
The Milan Breast Cancer
Observatory:
Innovation and care in the next 12 months
 Participants:
Leslie Ford
Aron Goldhirsch
Paul Goss
Virgilio Sacchini
Alphonse Taghian
Chair: Alberto Costa |
| 12.20 |
Lunch |
| 13.30 |
SPOTLIGHT:
The breast cancer survivors
Antonella Surbone |
| 13.40 |
SPOTLIGHT:
Cardiac toxicity in breast cancer survival
Thomas Suter |
|
ENDOCRINE ADJUVANT THERAPIES:
NEW
STANDARDS AND NEW AVENUES
Chair: Paul Goss
Rapporteur: Silvia Dellapasqua |
| 14.00 |
The evolving chapter of adjuvant aromatase
inhibitors
Paul Goss |
| 14.15 |
Ovarian function ablation and being a woman:
how to reconcile?
Antonio C. Wolff |
| 14.30 |
What would I want to know more about duration
of adjuvant endocrine therapies
James Ingle |
| 14.45 |
Discussion |
|
CHEMOTHERAPY, HER2/NEU AND OTHER
TARGETED THERAPIES
Chair: Antonella Surbone
Rapporteur: Rosalba Torrisi |
| 15.00 |
Adjuvant trastuzumab and beyond
Stefan Glück |
| 15.15 |
New information on HER2/neu and new targeted
therapies
Rosalba Torrisi |
| 15.30 |
Taxing the taxanes in adjuvant setting
Angelo Di Leo |
| 15.45 |
Discussion |
| 16.00 |
Coffee Break |
|
SYSTEMIC THERAPIES: SPECIAL ISSUES
Chair: Antonio C. Wolff
Rapporteur: Laura Orlando |
| 16.30 |
Tailored preoperative systemic therapy:
new aspects for targeting treatments
Marco Colleoni |
| 16.45 |
The axillary lymph node metastases with
no primary breast cancer: what to do?
Virgilio Sacchini |
| 17.00 |
Discussion and Closing remarks |
HOME PAGE
Wed, 20 june 2007